| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/27/1997 | WO1997007214A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 02/27/1997 | WO1997007212A1 Opioid antagonists and methods of their use |
| 02/27/1997 | WO1997007208A1 Nucleic acid molecules encoding peptides having pronociceptive properties |
| 02/27/1997 | WO1997007130A1 Novel opioid peptides |
| 02/27/1997 | WO1997007120A1 Biphenyl(thio)amide and biphenylethan(thi)one derivatives, their preparation and their use as 5-ht1d receptor antagonists |
| 02/27/1997 | WO1997007116A1 Prolylendopeptidase inhibitors |
| 02/27/1997 | WO1997007115A1 Benzenesulphonamide derivatives as bradykinine antagonists |
| 02/27/1997 | WO1997007098A1 (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethanesulfonate trihydrate |
| 02/27/1997 | WO1997006806A1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 02/27/1997 | WO1997006800A1 Remedy for anxiety neurosis |
| 02/27/1997 | WO1997006799A1 Novel fused isoquinolines as dopamine receptor ligands |
| 02/27/1997 | WO1997006786A1 Oral fast-dissolving compositions for dopamine agonists |
| 02/27/1997 | WO1997003188A3 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 02/27/1997 | WO1996040885A3 β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION |
| 02/27/1997 | DE19531067A1 Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität Use of boswellic acid and its derivatives for the inhibition of the normal and increased Leukozytenelastase- or plasmin |
| 02/27/1997 | CA2235677A1 Prolylendopeptidase inhibitors |
| 02/27/1997 | CA2229797A1 Novel opioid peptides |
| 02/27/1997 | CA2229126A1 Opioid antagonists and methods of their use |
| 02/27/1997 | CA2228036A1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 02/27/1997 | CA2227585A1 Novel fused isoquinolines as dopamine receptor ligands |
| 02/26/1997 | EP0759296A1 Rapidly disintegrating formulation comprising tramadol or a tramadol salt |
| 02/26/1997 | EP0759087A1 Compositions and methods for targeting gene delivery vehicles |
| 02/26/1997 | EP0759079A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1$g(b) CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel?-III) |
| 02/26/1997 | EP0759027A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 02/26/1997 | EP0759026A1 Amide derivatives and their therapeutic use |
| 02/26/1997 | EP0759025A1 Amide derivatives and their therapeutic use |
| 02/26/1997 | EP0758902A1 Compositions and treatment for multiple sclerosis |
| 02/26/1997 | EP0758900A1 Method for reduction of headache pain |
| 02/26/1997 | EP0758892A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
| 02/26/1997 | EP0758891A1 HALOMETHYL AMIDES AS IL-1$g(b) PROTEASE INHIBITORS |
| 02/26/1997 | EP0758890A1 Use of no scavengers, inhibitors or antagonists in the treatment of migraine |
| 02/26/1997 | EP0732917A4 Nutritional supplement for optimizing cellular health |
| 02/26/1997 | EP0707581B1 Indoline derivatives as 5ht2c antagonists |
| 02/26/1997 | EP0673377B1 New triazoloquinazolines, their production and their use |
| 02/26/1997 | CN1143960A Heterocyclic compound for treatment |
| 02/26/1997 | CN1143953A Certain fused pyrrolecarboxanilides; new class of gaba brain receptor ligands |
| 02/26/1997 | CN1143644A N-|(1,4-diazadicyclo |2,2,2¨ oct -2-yl methyl¨ benzoic amide derivatives, its preparing process and medicinal use |
| 02/26/1997 | CN1143643A Paroxetine hydrochloride anhydrate substantially free of bound propan-2-ol |
| 02/26/1997 | CN1143642A New indole, indazole and benzisoxazole compounds, their process of preparation and pharmaceutical compositions which contain them |
| 02/26/1997 | CN1143628A N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
| 02/26/1997 | CN1034123C Calcium channel blocking polypeptides from filistate hibernalis |
| 02/26/1997 | CA2184052A1 Piperidinylmethyloxazolidinones |
| 02/25/1997 | US5606062 Stereoselective reduction |
| 02/25/1997 | US5606032 Extraction of vertebrate brain material to obtain protein; chromatographic purification |
| 02/25/1997 | US5605938 Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| 02/25/1997 | US5605930 Compositions and methods for treating and preventing pathologies including cancer |
| 02/25/1997 | US5605927 Treatment of skin diseases using ginkgolide PAF antagonists |
| 02/25/1997 | US5605925 1-aminoacetamidopyrroles and 1-amino acetamido-2-(substituted) pyrroles and related compounds |
| 02/25/1997 | US5605891 Administering glycosaminoglycans |
| 02/25/1997 | US5605825 Human PAK65 |
| 02/25/1997 | US5605808 Oncoprotein protein kinase |
| 02/25/1997 | CA2085135C Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
| 02/25/1997 | CA2049514C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 02/25/1997 | CA1338940C Ó,ó-disubstituted n-cycloalkylalkylbenzylamines, process for their preparation, their use as a medicament and their synthesis intermediates |
| 02/25/1997 | CA1338934C 3-aminomethyl derivatives of indane, indoline and ¬dihydro-benzo|-furane and thiophene |
| 02/20/1997 | WO1997006260A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/20/1997 | WO1997006255A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/20/1997 | WO1997006165A1 Aza-anthracyclinone derivatives |
| 02/20/1997 | WO1997006162A1 One pot synthesis of 2-oxazolidinone derivatives |
| 02/20/1997 | WO1997006159A1 Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives |
| 02/20/1997 | WO1997006155A1 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphthalen-1-yl)piperazine derivatives, preparation thereof and therapeutical use thereof |
| 02/20/1997 | WO1997006140A1 Acylated derivatives of melatonin and its analogues, useful as medicaments |
| 02/20/1997 | WO1997005894A1 Pharmaceutical composition containing il-10 |
| 02/20/1997 | WO1997005892A1 Use of betaglycan to reduce scarring |
| 02/20/1997 | WO1997005780A1 Regulation of alzheimer's disease related proteins and uses thereof |
| 02/20/1997 | DE19530884A1 Verwendung von Prostan-Derivaten sowie deren Kombination mit Antibiotika zur Behandlung von bakteriellen Infektionen Use of prostane derivatives and their combination with antibiotics to treat bacterial infections |
| 02/20/1997 | CA2512366A1 Mammalian iap gene family, primers, probes and detection methods |
| 02/20/1997 | CA2228843A1 1- 2-(2,3-dihydro-1h-inden-1-yl)ethyl -4-(naphth-1-yl) piperazine derivatives, their preparation and their application in therapeutics |
| 02/20/1997 | CA2228650A1 Use of betaglycan to reduce scarring |
| 02/20/1997 | CA2228286A1 Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives |
| 02/20/1997 | CA2225647A1 Regulation of alzheimer's disease related proteins and uses thereof |
| 02/20/1997 | CA2201282A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/19/1997 | EP0758648A1 Substituted 4H-pyrans with a modulating effect on calcium channels |
| 02/19/1997 | EP0758647A1 Acyl substituted aminopyrans with a modulating effect on calcium channels |
| 02/19/1997 | EP0758452A1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same |
| 02/19/1997 | EP0758330A1 Biphenylcarboxamides useful as 5-ht1d antagonists |
| 02/19/1997 | EP0758329A1 Morpholine derivatives and their use as antagonists of tachikinins |
| 02/19/1997 | EP0758312A1 Substituted fused and bridged bicyclic compounds as therapeutic agents |
| 02/19/1997 | EP0758252A1 TIN-117m-CONTAINING RADIOTHERAPEUTIC AGENTS |
| 02/19/1997 | EP0758238A1 Spiro-substituted azacycles as neurokinin-3 antagonists |
| 02/19/1997 | EP0485431B1 Partial agonists of the strychnine insensitive glycine modulatory site of the n-methyl-d-aspartate receptor complex as neuropsychopharmacological agents |
| 02/19/1997 | CN1143372A Haemopoietic manuration factor |
| 02/19/1997 | CN1143320A Sublingual or buccal pharmaceutical composition |
| 02/19/1997 | CN1143079A Benzo-iso-thiazolyl substituted amino methyl-benzodipyran |
| 02/19/1997 | CN1142945A Medcine for curing cerebrovascular disturbance with psychonosema |
| 02/19/1997 | CN1034077C Preparation of new pyrido|2,3-f¨|1,4¨ thiazepines |
| 02/19/1997 | CN1034072C Preparing method for tetrahydrocarbazole derivative |
| 02/18/1997 | US5604261 Having hydroxyl/alkoxyl group ortho to amide group on phenyl ring; high melatonin receptor affinity |
| 02/18/1997 | US5604252 Substance p antagonist |
| 02/18/1997 | US5604247 Chromone Derivatives |
| 02/18/1997 | US5604245 Use of 4-amino-1-(2-pyridyl)piperidines for the preparation of a medicament for the treatment of conditions deriving from disorders of the serotoninergic systems mediated by 5-HT3 receptors |
| 02/18/1997 | US5604242 Alkoxy- and carboxy-substituted piperidines for suppressing uptake of gamma-aminobutyric acid, analgesics, anxiolytic or antiepileptic agents |
| 02/18/1997 | US5604227 Excitatory amino acid antagonist; mono, di or tri-acetylation or alkylation |
| 02/18/1997 | US5604224 Substituted heterocyclylisoquinolinium salts and compositions and methods of use thereof |
| 02/18/1997 | US5604223 Treating epilepsy, nervous system disorder |
| 02/18/1997 | US5604221 Treating congestive heart failure, irritable bowel syndrome |
| 02/18/1997 | US5604216 Diluted mixtures for use as drugs or nutritional supplements |
| 02/18/1997 | US5604206 Complexes containing S(+) phenyl alkane acids and amino sugars |
| 02/18/1997 | US5603959 Non-steroidal anti-inflammatory drug linked with unsaturated fatty acid or alcohol; cytoprotective agents, side effect reduction |
| 02/18/1997 | US5603957 Microcapsules for the controlled release of acetylsalicyclic acid in the gastrointestinal environment |